Alofisel - direct healthcare professional communication (DHPC)

darvadstrocel
DHPCHuman

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

O stronie

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumenty

Direct healthcare professional communication (DHPC): Alofisel (darvadstrocel): Withdrawal from the EU market as its clinical benefit is no longer demonstrated to justify its continued use

English (EN) (85.3 KB - PDF)

Opublikowane po raz pierwszy:
Zobacz

Key facts

Medicine name
Alofisel
Active substance
darvadstrocel
Therapeutic area (MeSH)
Rectal Fistula
Regulatory outcome
Withdrawal
DHPC type
Lack of effect
Human ATC codes
L04
Dissemination date

Share this page